Latest News about PTCT
Recent news which mentions PTCT
From Benzinga
From Benzinga
This National Vision Holdings Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday
May 09, 2025
From Benzinga
From Benzinga
This Logitech International Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday
May 07, 2025
From Benzinga
Earnings Scheduled For May 6, 2025
May 06, 2025
From Benzinga
Why Did PTC Therapeutics Stock Fall On Monday Despite Mid-Stage Study For Huntington's Hits Primary Goal?
May 05, 2025
From Benzinga
Dow Heads For 10 Straight, S&P 500 Wavers
May 05, 2025
From TalkMarkets
From Benzinga
From Benzinga
9 Health Care Stocks With Whale Alerts In Today's Session
April 22, 2025
From Benzinga
European Commission Declines To Renew Marketing Authorization Of Translarna Duchenne Muscular Disorder
March 28, 2025
From Benzinga
PTC Therapeutics Reveals New Sepiapterin Data From Phase 3 Study In Patients With Inherited Disorder, FDA Decision Expected In July
March 20, 2025
From Benzinga
From Benzinga
Earnings Scheduled For February 27, 2025
February 27, 2025
From Benzinga
Novartis Touts Encouraging Data From Late-Stage Study For Fabhalta In Rare Type Of Blood Disorder
December 06, 2024
From Benzinga
Bank of America To Rally More Than 21%? Here Are 10 Top Analyst Forecasts For Tuesday
December 03, 2024
From Benzinga
PTC Therapeutics Inks Licensing Pact With Novartis Worth Up To ~$3 Billion For Huntington's Program
December 02, 2024
From Benzinga
XPeng, NovoCure, Merus, Gap And Other Big Stocks Moving Higher On Monday
December 02, 2024
From Benzinga
From Benzinga
FDA Grants Conditional Approval For PTC Therapeutics' Gene Therapy As First Ever With Direct Administration In Brain
November 14, 2024
From Benzinga
3 Top Stocks That Could Still Rocket Higher in 2024
October 04, 2024
From Motley Fool
Tickers
PTCT
From InvestorPlace
From Benzinga
Asana, Clover Health Investments, Hertz Global And Other Big Stocks Moving Higher On Friday
June 21, 2024
From Benzinga
PTC Therapeutics Says FDA Lifts Clinical Hold On Investigational Study In Patients With Rare Weak Nerve Cell Disorder
June 20, 2024
From Benzinga
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.